Biologics Prescribers Collaborative

One-Pager Biologics, Biosimilars & Oncology

Event Report & Social Images Prescriber Perspectives: Policies Impacting Biosimilar Access

One-Pager Biologics, Biosimilars & Rheumatic Disease

Video National Policy & Advocacy Summit on Biologics Recording

Event Report National Policy & Advocacy Summit on Biologics Report

Video Biologics and Biosimilars: Increasing Treatment Options

Survey Results Patients’ Understanding of Biological Medicines: Survey Findings

Meeting Report Making Biosimilars Work

Infographic Biologics & Biosimilars 101

One-Pager The Biosimilars Pathway 101

Infographic Is the Biosimilars Pathway Working for Patients?

Educational Video The Path to Approval

The Center for Biosimilars, Proposed CMS Changes Are the Wrong Way to Save Money and Will Harm Patients and Providers

Non-Medical Switching Principles and Guidelines

Updated Handbook The Biosimilar Promise: An Introduction for Prescribers

Biologics Prescribers Collaborative to Speak at FDA Hearing on Biosimilars

About the Biologics Prescribers Collaborative

The Biologics Prescribers Collaborative aims to ensure that sound policies are in place to promote the safest possible use of all biologics, including biosimilars, for all patients.

Learn More About Us

Co-conveners

Dennis R. Cryer, MD

Genetics and Metabolism

Washington, DC

Gregory Schimizzi, MD

Rheumatology

Wilmington, NC

David Charles, MD

AfPA National Chairman Neurology

Nashville, TN

Arturo Loaiza-Bonilla, MD

Oncology

Philadelphia, PA

Rolf Benirschke

Patient Advocate

San Diego, CA